Pathogenic variants in BC/OC susceptibility genes with a high penetrance (BRCA1, BRCA2, CDH1, PALB2, PTEN, STK11, and TP53) lead to a significantly increased risk of developing BC and/or OC. This evidence concerns the gene PALB2 and breast cancer.